Free Trial

Apollomics (APLMW) Competitors

$0.04 -0.01 (-19.19%)
As of 07/1/2025 03:11 PM Eastern

APLMW vs. ATNFW, SXTPW, DRTSW, WENAW, BCTXW, CDIOW, CTCXW, CELUW, CEROW, and CINGW

Should you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), CERo Therapeutics (CEROW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry.

Apollomics vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Apollomics N/A N/A N/A

In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.87 equaled Apollomics'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Very Positive
Apollomics Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
ApollomicsN/AN/AN/AN/AN/A

Summary

180 Life Sciences and Apollomics tied by winning 0 of the 0 factors compared between the two stocks.

Get Apollomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APLMW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APLMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APLMW vs. The Competition

MetricApollomicsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$123.89M$5.48B$8.94B
Dividend YieldN/A3.74%5.38%4.12%
P/E RatioN/A3.2826.2119.74
Price / SalesN/A3,653.26395.51109.12
Price / CashN/A13.1936.4957.06
Price / BookN/A43.047.915.37
Net IncomeN/A-$92.79M$3.15B$248.34M
7 Day PerformanceN/A0.25%0.77%1.67%
1 Month PerformanceN/A2.04%3.46%4.56%
1 Year PerformanceN/A180.98%34.61%18.42%

Apollomics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APLMW
Apollomics
N/A$0.04
-19.2%
N/A+155.7%$0.00N/A0.0059Positive News
Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-1.2%
N/A-14.0%$0.00N/A0.007Positive News
Gap Down
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
-1.2%
N/A-19.5%$0.00$665.45K0.002Positive News
Gap Up
DRTSW
Alpha Tau Medical
N/A$0.24
-3.7%
N/A-3.1%$0.00N/A0.0080News Coverage
Positive News
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.07
+13.4%
N/A-72.7%$0.00N/A0.008Gap Up
CDIOW
Cardio Diagnostics
N/A$0.01
-2.2%
N/A-61.8%$0.00$19.90K0.007Positive News
CTCXW
Carmell
N/A$0.03
+6.8%
N/A-63.2%$0.00$32.84K0.0014Gap Up
CELUW
Celularity
N/A$0.04
flat
N/A+209.1%$0.00$54.22M0.00220
CEROW
CERo Therapeutics
N/A$0.03
+5.6%
N/A+2.0%$0.00N/A0.008Positive News
Gap Down
CINGW
Cingulate
N/A$0.07
-11.8%
N/A+432.4%$0.00N/A0.0020Gap Down

Related Companies and Tools


This page (NASDAQ:APLMW) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners